ArticleClinical medicine insights. Blood disorders2015

Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases.

Halima El Omri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.